GCC Minimally Invasive Surgery Market to Reach US$ 1,960.6 Million by 2032, Accelerated by Increasing Prevalence of Chronic Illnesses

As per the latest report by IMARC Group, titled "GCC Minimally Invasive Surgery Market Report by Product Type (Surgical Devices, Laparoscopy Devices, Monitoring and Visualization Devices), Application (Bariatric Surgery, Breast Surgery, Cardiac Surgery, Cosmetic Surgery, Gastrointestinal Surgery, Gynaecological Surgery, Orthopedics and Spine Surgery, Thoracic Surgery, and Others), End User (Hospitals, Clinics, and Others), and Country 2024-2032," the GCC minimally invasive surgery market size reached US$ 1,032.9 Million in 2023. Minimally invasive surgery (MIS) is a medical technique that uses advanced technology to perform surgery with minimal damage to surrounding tissue. It utilizes small surgical instruments, cameras, and specialized lighting systems that allow the surgeon to visualize the surgical site through a small incision, enabling them to perform the procedure precisely and accurately. MIS offers various advantages over traditional open surgery, including smaller incisions, less pain, shorter hospital stays, faster recovery times, and fewer complications. It also provides a lower risk of infection and scarring. Some standard types of MIS include laparoscopy, endoscopy, and robotic surgery. Among these, laparoscopy involves inserting a small camera and other instruments through small incisions in the abdomen, while the equipment used in endoscopy is inserted through the mouth or anus. On the other hand, robotic surgery employs a robotic system to perform the surgery with the assistance of a surgeon. MIS is commonly used for procedures such as gallbladder removal, hernia repair, and appendectomy, among others.

GCC Minimally Invasive Surgery Market Trends: 

The increasing incidence of chronic diseases, such as cancer and cardiovascular disease, represents the key factor fueling the minimally invasive surgery market in GCC. In line with this, the burgeoning population and the rising consumer awareness regarding the multiple advantages of MIS over traditional open surgeries, including cost-effectiveness, lower rates of complications, and reduced blood loss, are bolstering the market growth. Additionally, governments in the GCC region are increasingly investing in improving healthcare infrastructure. They are also organizing programs promoting the use of minimally invasive surgeries to improve patient outcomes and reduce healthcare costs, which, in turn, is creating a positive outlook for the market. Apart from this, significant technological advancements, such as the development of specialized surgical instruments, laparoscopes, and high-resolution cameras that have allowed surgeons to perform complex procedures through small incisions, are propelling the market growth. Other factors, such as burgeoning healthcare expenditure and inflating consumer expenditure power, are providing an impetus to market growth. Looking forward, the market value is projected to reach US$ 1,960.6 Million by 2032, expanding at a CAGR of 7.2% during 2024-2032. 

Market Summary: 

• By the product type, the market is segmented into surgical devices, laparoscopy devices, and monitoring and visualization devices.
• Based on the application, the market is categorized into bariatric, breast, cardiac, cosmetic, gastrointestinal, gynaecological, orthopedics and spine, thoracic, and other surgeries.
• On the basis of the end user, the market is divided into hospitals, clinics, and others.
• By the country, the market is segregated into Saudi Arabia, the UAE, Qatar, Oman, Kuwait, and Bahrain.
• The competitive landscape of the industry has also been examined along with the profiles of the key players.
   

Report Scope:

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group
134 N 4th St.
Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800